What Can Korean Pharma Do Right To Build R&D, Alliances?
This article was originally published in PharmAsia News
What is an ideal R&D business model for the South Korean pharma industry and what are some of the key factors that could lead to successful novel research? At a recent meeting in Seoul, executives from leading domestic pharma companies including Yuhan and Hanmi shared their views and experience on how to develop valuable assets and seal successful international licensing deals.
Register for our free email digests: